Health FDA Mandates New Warning Labels on Ozempic, Wegovy Over Rare Vision Loss Risk November 10, 2026 The U.S. Food and Drug Administration announced Monday it will require new warnings on all glucagon-like peptide-1 receptor agonist medications over a potential increased risk for a rare eye condition…